Developmental pharmacology and toxicology: Biotransformation of drugs and other xenobiotics during postnatal development Wolfgang Klinger OriginalPaper Pages: 3 - 17
[2-14C]Thymidine incorporation activity of stem cells in either tumor or cradle tissues in a normal or transplanted animals Akiyo ShigematsuJoji YuiAkiko Hatori OriginalPaper Pages: 29 - 39
Statistical aspects of bioequivalence testing between two medicinal products E. Zintzaras OriginalPaper Pages: 41 - 46
Transport of thalidomide by the human intestinal Caco-2 monolayers Shufeng ZhouYan LiJames W. Paxton OriginalPaper Pages: 49 - 61
Development of a HPLC-MS assay for ginsenoside Rh2, a new anti-tumor substance from natural product and its pharacokinetic study in dogs Hai-Tang XieGuang-Ji WangMei-Juan Xu OriginalPaper Pages: 63 - 67
Different effect of erythromycin on absorption kinetics of nimodipine in male and female rats X. D. LiuXL WangG. J. Wang OriginalPaper Pages: 69 - 73
The use of the suicide CYP450 inhibitor ABT for distinguishing absorption and metabolism processes in in-vivo pharmacokinetic screens Gary W. CaldwellDavid M. RitchieWilliam Jones OriginalPaper Pages: 75 - 83
Influence of different calcic antagonists on the Caco-2 cell monolayer integrity or “TEER, a measurement of toxicity ?” F. MathieuM. -J. GalmierC. Lartigue OriginalPaper Pages: 85 - 90
In vitro andin vivo metabolism of ethyl 4-[(2-hydroxy-1-naphthyl)azo]benzoate Banu BekceGöksel SenerSevim Rollas OriginalPaper Pages: 91 - 97
Biopharmaceutical characterization of sustained release matrix tablets based on novel carbomer polymers: formulation and in vivo investigation Jelena ParojčićZorica DjurićIvan Kovačevic OriginalPaper Pages: 99 - 104
Metabolism of the α-1A-adrenergic receptor antagonist, pyridine-phenylpiperazine analog (RWJ-69597), in rat, dog and human hepatic S9 factions -API-MS/MS identification of metabolites W. N. WuL. A. MckownG. H. Kuo OriginalPaper Pages: 105 - 111
Metabolism of the new α-1A-adrenergic receptor antagonist, phthalimide-phenylpiperazine analog (RWJ-69442), in rat, dog and human hepatic S9 fractions, and in rats W. N. WuL. A. MckownG. H. Kuo OriginalPaper Pages: 113 - 120
Pharmacokinetic and pharmacodynamic of irbesartan in renal hypertensive dogs under non-steady-state and steady-state conditions Xiao-Hui HuangFu-Rong QiuJun Li OriginalPaper Pages: 121 - 126
Detection of nimesulide metabolites in rat plasma and hepatic subcellular fractions by HPLC-UV/DAD and LC-MS/MS studies Ş. Güniz Küçükgüzelİlkay KüçükgüzelSevİm Rollas OriginalPaper Pages: 127 - 134
